Evidence map›Paper›PMID 37511126›Full record

ArticleInternational journal of molecular sciences2023

Spatially Resolved Proteomic and Transcriptomic Profiling of Anaplastic Lymphoma Kinase-Rearranged Pulmonary Adenocarcinomas Reveals Key Players in Inter- and Intratumoral Heterogeneity.

Beáta Szeitz, Tibor Glasz, Zoltán Herold, Gábor Tóth, Mirjam Balbisi, János Fillinger, Szabolcs Horváth, Réka Mohácsi, Ho Jeong Kwon, Judit Moldvay and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Beáta SzeitzDivision of Oncology, Department of Internal Medicine and Oncology, Semmelweis University, 1083 Budapest, Hungary.ORCID 0000-0001-6414-0537
Tibor GlaszDepartment of Pathology, Forensic and Insurance Medicine, Semmelweis University, 1091 Budapest, Hungary.
Zoltán HeroldDivision of Oncology, Department of Internal Medicine and Oncology, Semmelweis University, 1083 Budapest, Hungary.ORCID 0000-0001-5990-4889
Gábor TóthMS Proteomics Research Group, Institute of Organic Chemistry, Research Centre for Natural Sciences, 1117 Budapest, Hungary.ORCID 0000-0003-1428-7906
Mirjam BalbisiMS Proteomics Research Group, Institute of Organic Chemistry, Research Centre for Natural Sciences, 1117 Budapest, Hungary.ORCID 0000-0002-6917-6974
János FillingerDepartment of Pathology, National Korányi Institute of Pulmonology, 1121 Budapest, Hungary.
Szabolcs HorváthDepartment of Pathology, National Korányi Institute of Pulmonology, 1121 Budapest, Hungary.
Réka MohácsiDivision of Oncology, Department of Internal Medicine and Oncology, Semmelweis University, 1083 Budapest, Hungary.
Ho Jeong KwonDepartment of Biotechnology, Division of Life Sciences, Yonsei University, Seoul 03722, Republic of Korea.ORCID 0000-0002-6919-833X
Judit Moldvay1st Department of Pulmonology, National Korányi Institute of Pulmonology, 1121 Budapest, Hungary.
Lilla TuriákMS Proteomics Research Group, Institute of Organic Chemistry, Research Centre for Natural Sciences, 1117 Budapest, Hungary.ORCID 0000-0002-2139-8156
Attila Marcell SzászDivision of Oncology, Department of Internal Medicine and Oncology, Semmelweis University, 1083 Budapest, Hungary.
Semmelweis University · HUOrszágos Korányi Tbc és Pulmonológiai Intézet · HUInstitute of Organic Chemistry · HUYonsei University · KR

Funding

Hungarian Academy of Sciences János Bolyai Research ScholarshipHungarian National Research, Development and Innovation Office K129065National Research, Development and Innovation Fund of Hungary KNN121510National Research, Development, and Innovation Fund of Hungary FK 131603National Research Foundation of Korea MSIP; 2016K2A9A1A03904900 and 2021R1A3B1077371New National Excellence Program of the Ministry for Culture and Innovation ÚNKP-22-3-IISemmelweis 250+ Excellence PhD Scholarship EFOP-3.6.3-VEKOP-16-2017-00009
6 · The paper itself

Abstract

Pulmonary adenocarcinomas (pADCs) with an

Indexed as

AdenocarcinomaAdenocarcinoma of LungLung NeoplasmsAnaplastic Lymphoma KinaseGene RearrangementHumansPilot ProjectsProteomicsReceptor Protein-Tyrosine KinasesTranscriptomeTumor MicroenvironmentAnaplastic Lymphoma KinaseReceptor Protein-Tyrosine KinasesALK rearrangementdigital spatial profilinglung adenocarcinomamulti-omicsproteomicspulmonary adenocarcinomatranscriptomics

Identifiers

PMID37511126
PMCPMC10380216
OpenAlexW4384202896

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.